TY - JOUR
T1 - Late-onset clozapine-induced agranulocytosis in a young woman with paranoid schizophrenia
AU - Vinayaka, Anuhya
AU - Sheshadri, Shubha
AU - Madhyastha, Sharath
AU - Shetty, Ganesh
AU - Reddy, Charan
N1 - Publisher Copyright:
© 2020 Wolters Kluwer Medknow Publications. All rights reserved.
PY - 2020/10/1
Y1 - 2020/10/1
N2 - Treatment of schizophrenia has taken so many turns, and adverse effects of the drugs still continue to remain as a hurdle in the management. Clozapine is considered to be the better promising drug in the treatment of paranoid schizophrenia with minimal side effects. Clozapine-induced agranulocytosis is one adverse event that troubles clinicians, and it requires a vigilant eye to look for the signs. In the present study, the authors discuss a case which has developed agranulocytosis in the later stages of clozapine treatment.
AB - Treatment of schizophrenia has taken so many turns, and adverse effects of the drugs still continue to remain as a hurdle in the management. Clozapine is considered to be the better promising drug in the treatment of paranoid schizophrenia with minimal side effects. Clozapine-induced agranulocytosis is one adverse event that troubles clinicians, and it requires a vigilant eye to look for the signs. In the present study, the authors discuss a case which has developed agranulocytosis in the later stages of clozapine treatment.
UR - http://www.scopus.com/inward/record.url?scp=85106152652&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85106152652&partnerID=8YFLogxK
U2 - 10.4103/jpp.JPP_29_20
DO - 10.4103/jpp.JPP_29_20
M3 - Article
AN - SCOPUS:85106152652
SN - 0976-500X
VL - 11
SP - 140
EP - 141
JO - Journal of Pharmacology and Pharmacotherapeutics
JF - Journal of Pharmacology and Pharmacotherapeutics
IS - 4
ER -